杨新玲 刘丽
【摘 要】目的:探讨罗哌卡因-舒芬太尼在硬膜外和腰-硬联合阻滞分娩镇痛中的应用效果。方法:选取我院2019年7月至2021年7月产科接受分娩阵痛的800例产妇为研究对象,随机分为两组,每组各400例,对照组产妇在硬膜外阻滞镇痛中应用罗哌卡因-舒芬太尼,研究组产妇在腰硬联合阻滞镇痛中应用罗哌卡因-舒芬太尼,比较两组产妇不同时刻的镇痛效果、麻醉用药量、自控镇痛次数。结果:研究组产妇分娩镇痛后5 min、10 min、20 min、30 min及宮口全开时的VAS评分均显著低于对照组(P<0.05);研究组产妇麻醉用药量及自控镇痛次数较对照组更少(P<0.05)。结论:腰硬联合阻滞镇痛中应用罗哌卡因-舒芬太尼镇痛效果安全显著,药物用量少,在分娩镇痛中具有较高的应用价值。
【关键词】罗哌卡因;舒芬太尼;腰硬联合阻滞;分娩镇痛;VAS评分
Application of ropivacaine sufentanil in epidural and combined spinal epidural block labor analgesia
Yang Xinling, Liu li
Shaanxi Province Chenggu County Hospital, Shaanxi Chenggu 723200, China
【Abstract】Objective: To investigate the effect of ropivacaine sufentanil in epidural and combined spinal epidural block labor analgesia. Methods: 800 pregnant women who underwent labor pains in obstetrics from July 2019 to July 2021 were randomly divided into two groups, with 400 cases in each group. The patients in the control group were treated with ropivacaine sufentanil in epidural block analgesia, and the patients in the study group were treated with ropivacaine sufentanil in combined spinal epidural block analgesia. The analgesic effects of the two groups at different times were compared Anesthetic dosage and times of patient-controlled analgesia were measured.Results: The VAS scores of the study group were significantly lower than those of the control group at 5 min, 10 min, 20 min, 30 min after labor analgesia and when the uterine orifice was fully opened(P<0.05).The dosage of anesthetic and the times of patient-controlled analgesia in the study group were less than those in the control group(P<0.05).Conclusion: The analgesic effect of ropivacaine sufentanil in combined spinal epidural block analgesia is safe and significant, and the drug dosage is small. It has high application value in labor analgesia.
【Key?Words】Ropivacaine; Sufentanil; Combined spinal epidural block; Labor analgesia; VAS score
妊娠分娩是育龄期妇女必经的生理过程,但分娩疼痛常会引发一系列神经内分泌反应,使产妇出现各种不良情绪而影响生理状态,不利于母婴健康[1]。分娩镇痛主要是应用局麻药物及阿片类镇痛药缓解产妇疼痛感,以提高自然分娩率及产妇舒适度。硬膜外阻滞与腰-硬联合阻滞均为临床常用的分娩镇痛方式,但不同方式取得的镇痛效果常存在一定差异性[2]。本研究选取我院产科接受分娩阵痛的800例产妇为研究对象,探讨罗哌卡因-舒芬太尼在硬膜外和腰-硬联合阻滞中的应用效果,现进行如下报道。
1.1 一般资料
选取我院2019年7月至2021年7月产科接受分娩阵痛的800例产妇为研究对象,将受试者进行随机分组,各400例。……